Ouro Fino Saúde Animal Participações S.A Total Assets

Latest as of March 2026: R$1.63 Billion BRL ≈ $320.00 Million USD

Ouro Fino Saúde Animal Participações S.A total assets. Based on the latest financial reports, Ouro Fino Saúde Animal Participações S.A (OFSA3) holds total assets worth R$1.63 Billion BRL (≈ $320.00 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see OFSA3 cash flow conversion for how efficiently the company converts equity into cash flow.

Total Assets of Ouro Fino Saúde Animal Participações S.A (2011–2025)

Total assets of Ouro Fino Saúde Animal Participações S.A from 2011 to 2025. This chart illustrates how Ouro Fino Saúde Animal Participações S.A's total assets have evolved over time, based on quarterly financial data. See Ouro Fino Saúde Animal Participações S.A (OFSA3) stock price for real-time trading data and today's change.

Ouro Fino Saúde Animal Participações S.A - Asset Composition Analysis

Ouro Fino Saúde Animal Participações S.A Total Assets Breakdown (December 2025)

Ouro Fino Saúde Animal Participações S.A total assets breakdown as of December 2025. Ouro Fino Saúde Animal Participações S.A's total assets of R$1.63 Billion consist of 65.4% current assets and 34.7% non-current assets. Explore OFSA3 net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Asset Category Amount (BRL) % of Total Assets
Cash & Equivalents R$0.00 16.0%
Accounts Receivable R$430.37 Million 27.5%
Inventory R$303.64 Million 19.4%
Property, Plant & Equipment R$0.00 0.0%
Intangible Assets R$105.22 Million 6.7%
Goodwill R$618.00K 0.0%

Asset Composition Trend (2011–2025)

This chart illustrates how Ouro Fino Saúde Animal Participações S.A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Ouro Fino Saúde Animal Participações S.A's current assets represent 65.4% of total assets in 2025, an increase from 0.0% in 2011.
  • Cash Position: Cash and equivalents constituted 16.0% of total assets in 2025, up from 7.7% in 2011.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 0.0% in 2011.
  • Asset Diversification: The largest asset category is accounts receivable at 27.5% of total assets.

Ouro Fino Saúde Animal Participações S.A Competitors by Total Assets

Key competitors of Ouro Fino Saúde Animal Participações S.A based on total assets are shown below.

Company Country Total Assets
GALDERMA GROUP AG
NYSE:GALDY
USA $13.39 Billion
Takeda Pharmaceutical Company Limited
F:TKDA
Germany €15.41 Trillion
Galderma Group N
SW:GALD
Switzerland CHF12.88 Billion
Enzymatica publ AB
ST:ENZY
Sweden Skr149.24 Million
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
China CN¥13.98 Billion
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
China CN¥17.01 Billion
Kangmei Pharmaceutical Co Ltd
SHG:600518
China CN¥13.68 Billion
Walvax BioTech
SHE:300142
China CN¥10.50 Billion

Ouro Fino Saúde Animal Participações S.A - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 3.46 2.56 3.82
Quick Ratio 2.41 1.44 2.40
Cash Ratio 0.00 0.46 0.87
Working Capital R$780.82 Million R$472.27 Million R$466.24 Million

Ouro Fino Saúde Animal Participações S.A - Advanced Valuation Insights

This section examines the relationship between Ouro Fino Saúde Animal Participações S.A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.78
Latest Market Cap to Assets Ratio 0.17
Asset Growth Rate (YoY) 13.1%
Total Assets R$1.57 Billion
Market Capitalization $261.22 Million USD

Valuation Analysis

Below Book Valuation: The market values Ouro Fino Saúde Animal Participações S.A's assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Ouro Fino Saúde Animal Participações S.A's assets grew by 13.1% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Ouro Fino Saúde Animal Participações S.A (2011–2025)

The table below shows the annual total assets of Ouro Fino Saúde Animal Participações S.A from 2011 to 2025.

Year Total Assets Change
2025-12-31 R$1.57 Billion
≈ $307.24 Million
+13.08%
2024-12-31 R$1.38 Billion
≈ $271.70 Million
+8.26%
2023-12-31 R$1.28 Billion
≈ $250.96 Million
-5.01%
2022-12-31 R$1.35 Billion
≈ $264.21 Million
+12.90%
2021-12-31 R$1.19 Billion
≈ $234.02 Million
+8.04%
2020-12-31 R$1.10 Billion
≈ $216.61 Million
+26.96%
2019-12-31 R$869.54 Million
≈ $170.62 Million
+2.78%
2018-12-31 R$846.01 Million
≈ $166.00 Million
+4.42%
2017-12-31 R$810.23 Million
≈ $158.98 Million
+4.47%
2016-12-31 R$775.58 Million
≈ $152.18 Million
+11.86%
2015-12-31 R$693.37 Million
≈ $136.05 Million
+10.54%
2014-12-31 R$627.26 Million
≈ $123.08 Million
+16.44%
2013-12-31 R$538.68 Million
≈ $105.70 Million
+19.14%
2012-12-31 R$452.13 Million
≈ $88.72 Million
-2.96%
2011-12-31 R$465.91 Million
≈ $91.42 Million
--

About Ouro Fino Saúde Animal Participações S.A

SA:OFSA3 Brazil Drug Manufacturers - Specialty & Generic
Market Cap
$261.22 Million
R$1.33 Billion BRL
Market Cap Rank
#15213 Global
#145 in Brazil
Share Price
R$24.76
Change (1 day)
-2.90%
52-Week Range
R$21.60 - R$33.78
All Time High
R$40.76
About

Ouro Fino Saúde Animal Participações S.A., together with its subsidiaries, engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil. The company operates through three segments: Production Animals; Companion Animals; and International Operations. It manufactures and trades in medicines, including an… Read more